NCT07385118

Brief Summary

Cognitive functions are fundamental to everyday life, underpinning the mental processes required to perform any activity. Recent studies have shown that improved cognitive performance is associated with elevated levels of brain-derived neurotrophic factor (BDNF), which can be increased through an acute bout of physical activity. However, daily variations of BDNF serum and plasma remain poorly characterised and are not fully understood, and their correlation with daily variations in cognitive performance has not been previously explored. This study examines: 1\) the correlation between daily BDNF fluctuations and cognitive performance. 2) whether a single session of exercise can elevate BDNF levels and lead to measurable cognitive improvements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2025

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2025

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2026

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 3, 2026

Completed
Last Updated

February 9, 2026

Status Verified

October 1, 2025

Enrollment Period

22 days

First QC Date

January 7, 2026

Last Update Submit

February 4, 2026

Conditions

Keywords

BDNFCognitionexercise

Outcome Measures

Primary Outcomes (4)

  • Levels of Serum BDNF (ng/ml)

    Blood samples for serum BDNF concentration analysis were collected using a Clot Activator Tube (CAT) and gently swirled ten times, upside down. They were then incubated at room temperature for 30 minutes to allow clot formation. Subsequently, the samples were centrifuged at 1100 g and 4 °C for 10 minutes, and then, the serum was collected, aliquoted, and stored at -80 °C. The analysis of BDNF was performed using an enzyme-linked immunosorbent assay (ELISA) kit, following the manufacturer's instructions (ab212166 - Human BDNF SimpleStep ELISA Kit).

    blood samples were collected on day one and day two at five specific time points: 9 a.m. (t1), 11 a.m. (t2), 1 p.m. (t3), 3 p.m. (t4), 5 p.m. (t5)

  • inhibitory control

    Inhibitory control was assessed with the Flanker Task. During the task, participants are required to indicate the left-right orientation of a centrally presented stimulus while inhibiting attention to the potentially incongruent stimuli surrounding it (e.g., flankers on either side). The principal outcomes for this task are total errors, the mean reaction time for incongruent and congruent stimuli, and the conflict cost (the difference between the mean reaction times for incongruent and congruent stimuli)

    The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)

  • working memory (short-term memory)

    Working memory was assessed with the Digit Span Backwards, in which participants are presented with a series of digits and then asked to recall them in reverse order. The main outcome for this test is the memory span.

    The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)

  • sustained attention and vigilance

    Sustained attention and vigilance were assessed with the Psychomotor Vigilance Task. Participants are presented with a visual stimulus (a simple light) that appears at random inter-stimulus intervals (between 2 and 10 seconds). When the stimulus appears, the participants are required to respond as quickly as possible. The primary outcome for this test is the mean reaction time

    The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)

Study Arms (1)

BDNF arm

EXPERIMENTAL

Every subject will be tested on day 1 and day 2 with the same protocol. Blood samples will be collected at five time points throughout the workday: 09:00 (T1), 11:00 (T2), 13:00 (T3), 15:00 (T4), and 17:00 (T5), to assess potential diurnal variations in BDNF. Cognitive performance will be evaluated using the Psychomotor Vigilance Test (PVT), the Flanker task, and the Digit Span Backwards test at T1, T3, and T5. On the second intervention day, the same protocol will be followed, with the addition of a 15-minute single bout of high-intensity physical activity executed at T4.

Other: Exercise

Interventions

A five-minute bout of exercise at high intensity (75% of HRmax) repeated for two rounds with a minute rest between rounds. The bout consists of 5 exercises: BW squat, jumping jacks, lunges, crunches and step up. The modality is, in one minute for every exercise, 30 seconds of work and 30 seconds of rest

BDNF arm

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • an age between 18-40 years old
  • no history of mental or physical diseases (of a neurological, psychogenic, musculoskeletal, cardiorespiratory or systemic nature)
  • MoCA score higher than 26

You may not qualify if:

  • smokers
  • individuals experiencing sleep-wake cycle disturbances in the week prior to the study
  • consumers of medications with CNS effects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Biomedical Sciences, University of Padua

Padua, PD, 10034, Italy

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Antonio Paoli

    University of Padua Department of Biomedical Sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2026

First Posted

February 3, 2026

Study Start

December 1, 2025

Primary Completion

December 23, 2025

Study Completion

December 23, 2025

Last Updated

February 9, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations